you are here:

Parnax Lab Ltd.

BSE Live

Jul 27, 16:00
25.30 -1.30 (-4.89%)
Volume
AVERAGE VOLUME
5-Day
3,844
10-Day
5,173
30-Day
4,324
1,405
  • Prev. Close

    26.60

  • Open Price

    25.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    -

  • Open Price

    -

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

Parnax Lab is not listed on NSE

ANNOUNCEMENTS ON Parnax Lab

  • Jul 19, 2021 21:53 Source: BSE

    Parnax Lab - Shareholding for the Period Ended June 30, 2021

    Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here

  • Jul 14, 2021 22:39 Source: BSE

    Parnax Lab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Dear Sir, Pursuant to the provisions of Regulation 74(5) or Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, Please find enclosed herewith Compliance Certificate received from the Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of our Company for the quarter ended 30th June, 2021. You are requested to take the same on record.

  • Jul 10, 2021 20:34 Source: BSE

    Parnax Lab - Statement Of Investor Complaints For The Quarter Ended June 2021

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0000
    Name of the Signatory :- Preet Vijay Kukreja
    Designation :- Company Secretary and Compliance Officer

  • Jun 30, 2021 22:02 Source: BSE

    Parnax Lab - Closure of Trading Window

    Dear Sir/Madam, Pursuant to BSE Circulars dated 2nd April, 2019 vide Ref No: LIST/COMP/01/2019-20 please note that the Trading Window for dealing in the securities of the Company shall remain closed for all Designated Persons with effect from 01st July, 2021 for the purpose of consideration of Unaudited Financial result for the quarter ended 30th June, 2021. The Trading Window shall open 48 hours after the Unaudited Financial Result for the quarter ended 30th June, 2021 become generally available to the Public. The above is for your information and record. Kindly take the same on your record and oblige.

  • Jun 30, 2021 21:56 Source: BSE

    Parnax Lab - Results-Audited Financial Results For The Quarter And Year Ended March 31, 2021.

    Kindly find enclosed herewith the following: 1. A Copy of Standalone and Consolidated Audited Financial results for the quarter and year ended 31st March, 2021 along with Auditor Report thereon; 2. Declaration pursuant to Regulation 33(3)(d) as amended by the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. Kindly take the above in your record.

  • Jun 30, 2021 21:49 Source: BSE

    Parnax Lab - Outcome Of Board Meeting

    Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Wednesday, 30th June, 2021 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and year ended 31st March, 2021. 2. Considered and took note of Limited Review Report for the quarter and year ended 31st March 2021. The Meeting was commenced at 5.00 p.m. and concluded at 9.40 p.m. Kindly take the same on your record.

  • Jun 23, 2021 20:54 Source: BSE

    Parnax Lab - Board Meeting Intimation for Approval Of Audited Stand-Alone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2021.

    PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Standalone and Consolidated Audited IND-AS compliant Financial Results along with Auditor Report for the quarter and year ended on 31st March, 2021 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including at least one Independent Director.

  • Jun 21, 2021 19:23 Source: BSE

    Parnax Lab - Appointment of Company Secretary and Compliance Officer

    Dear Sir, This is to inform you that in the meeting of the Board of Directors of the Company Parnax Lab Limited held on 21st June, 2021, Mrs. Preet Vijay Kukreja has been appointed as the Key Managerial Personnel (Company Secretary and Compliance Officer) w.e.f. 21st June, 2021. The meeting commenced at 6.30 p.m. concluded at 7.00 p.m. This is for your information. Kindly take the same on your record.

  • Jun 21, 2021 19:19 Source: BSE

    Parnax Lab - Outcome Of The Board Meeting Held On 21ST June, 2021.

    Dear Sir, This is to inform you that in the meeting of the Board of Directors of the Company Parnax Lab Limited held on 21st June, 2021, Mrs. Preet Vijay Kukreja has been appointed as the Key Managerial Personnel (Company Secretary and Compliance Officer) w.e.f. 21st June, 2021. The meeting commenced at 6.30 p.m. concluded at 7.00 p.m. This is for your information. Kindly take the same on your record.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jun 30, 2021
Remark : Quarterly Results